Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
Article Details
- CitationCopy to clipboard
Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, El-Gazzar MG
Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
Arzneimittelforschung. 2012 Jan;62(1):46-52. doi: 10.1055/s-0031-1295496. Epub 2012 Jan 10.
- PubMed ID
- 22331763 [ View in PubMed]
- Abstract
The objective of this work is to synthesize and investigate the anticancer activity of a new series of sulfaquinoxaline derivatives by incorporating biologically active moieties (thiourethane, thiazole, imidazole, imidazopyrimidine, imidazopyrimido-pyrimidine, thienopyrimidine, benzopyrimidinone, benzothiazole, thiazole and pyridine moieties). All the newly synthesized compounds were evaluated for their in-vitro anticancer activity against human liver cell line (HEPG2). All the tested compounds showed comparable activity to that of the reference drug 5-fluorouracil (IC50=40 microM), and the most potent compounds were found to be compounds 4 and 17 (IC50=4.29 and 11.27 microM, respectively). On the other hand, the most potent compounds 4 and 17 were evaluated as radiosensitizing agents.
DrugBank Data that Cites this Article
- Drugs